Clicky

Hyundai Bioscience Co. Ltd(048410)

Description: Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.


Keywords: Biotechnology Organic Compounds Nutrition Vitamins Drug Delivery System Nutrients

Home Page: www.hyundaibioscience.com

Academic Cooperation Building
Seoul,
South Korea
Phone: 82 70 7008 0114


Officers

Name Title
Jong-Won Choi Joint Chief Exec. Officer
Ho-Suk Chon Joint Chief Exec. Officer
Yeong-Jin Kim Pres
Seok-Yong Choi Chief Operating Officer and Sr. Managing Director
Beom-Chan Jeong Sr. Managing Director
Chang-Hyoen Lee Managing Director
Soon-Ho Hong Managing Director

Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 82.5439
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks